Vaccination Coverage by Age 24 Months Among Children Born in 2015 and 2016 - National Immunization Survey-Child, United States, 2016-2018.
Vaccination Coverage by Age 24 Months Among Children Born in 2015 and 2016 - National Immunization Survey-Child, United States, 2016-2018. MMWR Morb Mortal Wkly Rep. 2019 Oct 18;68(41):913-918 Authors: Hill HA, Singleton JA, Yankey D, Elam-Evans LD, Pingali SC, Kang Y Abstract The Advisory Committee on Immunization Practices (ACIP) recommends that children be vaccinated against 14 potentially serious illnesses during the first 24 months of life (1). CDC used data from the National Immunization Survey-Child (NIS-Child) to assess vaccination coverage with the recommended number of doses of each vaccine at the national, state, territorial, and selected local levels* among children born in 2015 and 2016. Coverage by age 24 months was at least 90% nationally for ≥3 doses of poliovirus vaccine, ≥1 dose of measles, mumps, and rubella vaccine (MMR), ≥3 doses of hepatitis B vaccine (HepB), and ≥1 dose of varicella vaccine, although MMR coverage was
[Nation] Safaricom has partnered with the Ministry of Health and Korea Telecom to launch a new service that will alert subscribers on disease outbreaks whenever they travel abroad.
[Nation] The United States has for the first time explained why it has cut health funding to the Kenyan government, saying that the move was not malicious but driven by programmes and data.
Abstract Type I interferons (IFNs) facilitate cancer immunosurveillance, antitumor immunity and antitumor efficacy of conventional cell death-inducing therapies (chemotherapy/radiotherapy) as well as immunotherapy. Moreover, it is clear that dendritic cells (DCs) play a significant role in aiding type I IFN-driven immunity. Owing to these antitumor properties several immunotherapies involving, or inducing, type I IFNs have received considerable clinical attention, e.g., recombinant IFNα2 or agonists targeting pattern recognition receptor (PRR) pathways like Toll-like receptors (TLRs), cGAS-STING or RIG-I/MDA...
[New Times] Rwanda and the Democratic Republic of the Congo Sunday unveiled a massive vaccination campaign against Ebola Virus Disease (EVD) for their residents who live within the vicinity of a possible Ebola outbreak.
[New Times] Among the avenues that will put healthcare ahead of HIV/Aids is the development of vaccines, cures and multiple prevention mechanisms.
Volunteers in the New Zealand city of Rotorua are preparing two dozen white-lined coffins to be transported to Samoa at the end of the week as the measles-ravaged Pacific island nation languishes under a growing death toll that has now hit 70.
In conclusion, European countries now have more comprehensive national vaccination programs for HCP, however there are still gaps. Given the recent large outbreaks of vaccine-preventable diseases in Europe and the occupational risk for HCP, vaccination policies need to be expanded and strengthened in several European countries. Overall, vaccination policies for HCP in Europe should be periodically re-evaluated in order to provide optimal protection against vaccine-preventable diseases and infection control within healthcare facilities for HCP and patients. PMID: 31623916 [PubMed - as supplied by publisher]
Mark K. Slifka1* and Ian J. Amanna2 1Division of Neuroscience, Oregon National Primate Research Center, Oregon Health &Science University, Beaverton, OR, United States2Najít Technologies, Inc., Beaverton, OR, United States Vaccines play a vital role in protecting our communities against infectious disease. Unfortunately, some vaccines provide only partial protection or in some cases vaccine-mediated immunity may wane rapidly, resulting in either increased susceptibility to that disease or a requirement for more booster vaccinations in order to maintain immunity above a protective level. The durability of a...
This study aims to contribute to the ongoing reflections on tools and indicators of vaccine hesitancy by providing results of a survey on knowledge, attitudes and beliefs (KAB) of parents in Quebec (Canada). We have compared KAB of parents according to: 1) self-reported vaccination status of their child and 2) hesitation during the vaccination decision. Methods Data were collected through the 2014 Quebec study on vaccination against seasonal influenza and pneumococcal infections, a biennial repeated cross-sectional study in the province of Quebec, Canada. This paper presents the results pertaining to parents’ KAB ab...
Julia R. Barrett, MS, ELS, a Madison, WI–based science writer and editor, is a member of the National Association of Science Writers and the Board of Editors in the Life Sciences. About This Article open Citation: Barrett JR. 2015. Pediatric vaccines and neurodevelopment: primate study finds no adverse behavioral effects. Environ Health Perspect 123:A156; http://dx.doi.org/10.1289/ehp.123-A156 News Topics: Infectious Disease, Mental Health, Mercury, Neurologic Health Published: 1 June 2015 PDF Version (320 KB) Related EHP Article Examination of the Safety of Pediatric Vaccine Schedules in a Non-Human ...
More News: Children | Epidemiology | Health Insurance | Health Management | Hepatitis | Hepatitis B | Hepatitis Vaccine | Influenza | Influenza Vaccine | Insurance | Measles | Measles Vaccine | Medicaid | Mumps | Mumps Vaccine | Outbreaks | Rubella | Rubella Vaccine | Uninsured | USA Health | Vaccines